IPP Bureau
BGS Gleneagles Global Hospital unveils #SelfE campaign to fight breast cancer early
By IPP Bureau - February 04, 2022
The objective behind introducing this extraordinary digital campaign is to spread awareness among Gen X and Z for the need of breast self-examination
Sputnik V vaccine granted full approval in Russia
By IPP Bureau - February 04, 2022
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world
Mylab launches CoviSwift for Covid-19 Point of Care testing
By IPP Bureau - February 03, 2022
Unlike “Fast PCR” platforms - which uses LAMP/Isothermal technology and not gold standard RT-PCR - CoviSwift has high accuracy and sensitivity and is suitable for airports and hospitals
Dr. Reddy’s impresses on sustainability and gender equality again
By IPP Bureau - February 03, 2022
Dr. Reddy’s included in S&P Global’s Sustainability Yearbook for the 2nd year and Bloomberg Gender-Equality Index for the 5th year in a row
Pristyn Care doubles it surgical centres to 800 in 2021
By IPP Bureau - February 03, 2022
Pristyn Care operates on an innovative full- stack Care Delivery model to ensure that high quality surgical care is offered to patients at an affordable cost
Cadila Healthcare reports Q3FY22 net profit at Rs. 500.4 Cr
By IPP Bureau - February 03, 2022
The company has reported total income of Rs. 3715.8 crores during the quarter ended December 31, 2021
Granules receives ANDA approval for anti-depressant medication
By IPP Bureau - February 03, 2022
It has a total of 50 ANDA approvals from USFDA
Universal vaccination for Covid-19 irrational: AIIMS Professor
By IPP Bureau - February 03, 2022
The need is to vaccinate people who have not contracted Covid-19
Caplin Point Q3FY22 PAT at Rs 74.95 cr.
By IPP Bureau - February 03, 2022
Caplin Point Laboratories has reported consolidated financial results for the period ended December 31, 2021.
USFDA approves first generic of Restasis
By IPP Bureau - February 03, 2022
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
Dr. Reddy's set to acquire Nimbus Health
By IPP Bureau - February 03, 2022
The acquisition will allow Dr. Reddy's to build on Nimbus Health's strengths and introduce medical cannabis-based medicines as a promising treatment option for patients
Zydus supplies first consignment of its Covid-19 vaccine ZyCoV-D
By IPP Bureau - February 02, 2022
The vaccine will be priced at Rs. 265 per dose and the applicator being offered at Rs. 93 per dose excluding GST
Alembic receives USFDA tentative approval for fesoterodine fumarate
By IPP Bureau - February 02, 2022
The tablets are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency
Panacea Biotec sells its domestic formulations business to Mankind Pharma
By IPP Bureau - February 02, 2022
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
Windlas Biotech concludes SAHPRA audit with an all-clear sign
By IPP Bureau - February 02, 2022
It will enable the company to branch out to new geographies and strengthen its presence in South Africa
